AIIMS New Delhi is India's flagship public medical institute; its Rotary Cancer Hospital and the National Cancer Institute campus at Jhajjar anchor government cancer research, and its investigators lead Indian studies in paediatric oncology, gallbladder cancer, PSMA radioligand therapy and low-cost CAR-T.
AIIMS New Delhi was created by an Act of Parliament in 1956 as India's flagship medical institute and hospital. Cancer care is concentrated in the Dr B.R. Ambedkar Institute Rotary Cancer Hospital, opened in 1983, and in the National Cancer Institute at Jhajjar, Haryana, a large AIIMS-run cancer campus commissioned from 2019 with proton therapy planned and a national biobank and screening research mandate. AIIMS investigators lead Indian studies in paediatric oncology, gallbladder cancer (unusually common in northern India), oral and cervical cancer screening, radiation oncology and nuclear medicine (PSMA and FAPI PET, radioligand therapy), and haematology including low-cost CAR-T development with IIT Bombay partners. It sets national training standards and publishes the largest volume of oncology research of any Indian public institution.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to All India Institute of Medical Sciences, including child institutions. 890 works · 5,242 citations · 67% open access · 7% clinical trials · 5% reviews.
Endocrinologist appointed Director of AIIMS New Delhi in 2026, India's premier public medical institute and home to the Dr. B.R. Ambedkar Institute Rotary Cancer Hospital.
A medical oncologist who led the cancer hospital at AIIMS Delhi for many years, trained a large share of India's medical oncologists and helped write the country's early cancer treatment standards.
Shares FAPI PET, PSMA PET, Radioligand therapy (beta emitters), Biliary tract cancer (cholangiocarcinoma).
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, Cervical cancer, Acute lymphoblastic leukaemia.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Acute lymphoblastic leukaemia.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, Biliary tract cancer (cholangiocarcinoma), Cervical cancer.
Shares The new AIIMS network (PMSSY), National Cancer Grid of India, Global oncology and access in low- and middle-income countries.
Shares National Cancer Grid of India, Global oncology and access in low- and middle-income countries, Acute lymphoblastic leukaemia, Head and neck squamous cell carcinoma.
Shares Global oncology and access in low- and middle-income countries, Cervical cancer, Acute lymphoblastic leukaemia, Head and neck squamous cell carcinoma.